These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 35669165)
1. EGFR Mutation Status and Subtypes Predicted by CT-Based 3D Radiomic Features in Lung Adenocarcinoma. Chen Q; Li Y; Cheng Q; Van Valkenburgh J; Sun X; Zheng C; Zhang R; Yuan R Onco Targets Ther; 2022; 15():597-608. PubMed ID: 35669165 [TBL] [Abstract][Full Text] [Related]
2. Predicting EGFR mutation subtypes in lung adenocarcinoma using Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319 [TBL] [Abstract][Full Text] [Related]
3. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma. Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901 [TBL] [Abstract][Full Text] [Related]
4. Prediction of EGFR mutation status in lung adenocarcinoma based on Tan JL; Xia L; Sun SG; Zeng H; Lu DY; Cheng XJ Am J Nucl Med Mol Imaging; 2023; 13(5):230-244. PubMed ID: 38023818 [TBL] [Abstract][Full Text] [Related]
5. Yang B; Ji HS; Zhou CS; Dong H; Ma L; Ge YQ; Zhu CH; Tian JH; Zhang LJ; Zhu H; Lu GM Transl Lung Cancer Res; 2020 Jun; 9(3):563-574. PubMed ID: 32676320 [TBL] [Abstract][Full Text] [Related]
6. 3D radiomics predicts EGFR mutation, exon-19 deletion and exon-21 L858R mutation in lung adenocarcinoma. Liu G; Xu Z; Ge Y; Jiang B; Groen H; Vliegenthart R; Xie X Transl Lung Cancer Res; 2020 Aug; 9(4):1212-1224. PubMed ID: 32953499 [TBL] [Abstract][Full Text] [Related]
7. Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status? Digumarthy SR; Padole AM; Gullo RL; Sequist LV; Kalra MK Medicine (Baltimore); 2019 Jan; 98(1):e13963. PubMed ID: 30608433 [TBL] [Abstract][Full Text] [Related]
8. Value of pre-therapy Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587 [TBL] [Abstract][Full Text] [Related]
9. [Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma]. Yang CS; Chen WD; Gong GZ; Li ZJ; Qiu QT; Yin Y Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):282-287. PubMed ID: 31014053 [No Abstract] [Full Text] [Related]
10. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule. Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378 [TBL] [Abstract][Full Text] [Related]
11. The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung Adenocarcinoma. Zhao W; Wu Y; Xu Y; Sun Y; Gao P; Tan M; Ma W; Li C; Jin L; Hua Y; Liu J; Li M Front Oncol; 2019; 9():1485. PubMed ID: 31993370 [No Abstract] [Full Text] [Related]
12. Development of a Nomogram Based on 3D CT Radiomics Signature to Predict the Mutation Status of EGFR Molecular Subtypes in Lung Adenocarcinoma: A Multicenter Study. Zhang G; Deng L; Zhang J; Cao Y; Li S; Ren J; Qian R; Peng S; Zhang X; Zhou J; Zhang Z; Kong W; Pu H Front Oncol; 2022; 12():889293. PubMed ID: 35574401 [TBL] [Abstract][Full Text] [Related]
13. Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas. Liu Y; Kim J; Balagurunathan Y; Li Q; Garcia AL; Stringfield O; Ye Z; Gillies RJ Clin Lung Cancer; 2016 Sep; 17(5):441-448.e6. PubMed ID: 27017476 [TBL] [Abstract][Full Text] [Related]
14. Combination of Li S; Li Y; Zhao M; Wang P; Xin J Korean J Radiol; 2022 Sep; 23(9):921-930. PubMed ID: 36047542 [TBL] [Abstract][Full Text] [Related]
15. Detailed identification of epidermal growth factor receptor mutations in lung adenocarcinoma: Combining radiomics with machine learning. Li S; Luo T; Ding C; Huang Q; Guan Z; Zhang H Med Phys; 2020 Aug; 47(8):3458-3466. PubMed ID: 32416013 [TBL] [Abstract][Full Text] [Related]
16. Dual-energy CT-based radiomics in predicting EGFR mutation status non-invasively in lung adenocarcinoma. Ma JW; Jiang X; Wang YM; Jiang JM; Miao L; Qi LL; Zhang JX; Wen X; Li JW; Li M; Zhang L Heliyon; 2024 Jan; 10(2):e24372. PubMed ID: 38304841 [TBL] [Abstract][Full Text] [Related]
17. Radiomic-Based Quantitative CT Analysis of Pure Ground-Glass Nodules to Predict the Invasiveness of Lung Adenocarcinoma. Xu F; Zhu W; Shen Y; Wang J; Xu R; Qutesh C; Song L; Gan Y; Pu C; Hu H Front Oncol; 2020; 10():872. PubMed ID: 32850301 [No Abstract] [Full Text] [Related]
18. CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses. Mei D; Luo Y; Wang Y; Gong J Cancer Imaging; 2018 Dec; 18(1):52. PubMed ID: 30547844 [TBL] [Abstract][Full Text] [Related]
19. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms. Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618 [TBL] [Abstract][Full Text] [Related]
20. Using combined CT-clinical radiomics models to identify epidermal growth factor receptor mutation subtypes in lung adenocarcinoma. Huo JW; Luo TY; Diao L; Lv FJ; Chen WD; Yu RZ; Li Q Front Oncol; 2022; 12():846589. PubMed ID: 36059655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]